Trial Profile
Phase II Study of Oxaliplatin in Combination With 5-Fluorouracil (5-FU) and Folinic Acid (FA) in Patients Who Have Failed First-Line Treatment for Locally Advanced or Metastatic Cervical Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 16 Nov 2008 New trial record.